REBECCA BOWER: Open Payments
NPI 1053372300 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 71 payments from 18 companies in 2025. Trend: 2023 $1,335 · 2024 $2,253 · 2025 $1,453
Food & beverage: $1,393Education: $60
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $227 |
| ABBVIE INC. | 10 | $213 |
| Janssen Biotech, Inc. | 9 | $167 |
| Regeneron Healthcare Solutions, Inc. | 7 | $157 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Galderma Laboratories, L.P. | 4 | $75 |
| Lilly USA, LLC | 3 | $63 |
| PFIZER INC. | 3 | $58 |
| STRATA Skin Sciences, Inc. | 6 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, RINVOQ, NEMLUVIO, XTRAC, LIBTAYO.
Industry payments across MD — which companies pay providers there.
